After Years of Waiting, Noel Tata Presides Unchallenged over India’s Biggest Business 
Despite years of confiscations, the Met still holds hundreds of pieces linked to alleged trafficking and looting figures 
Ex-Evergrande Boss Hui Ka Yan gets Life in Prison The World Health Organization announced on Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.
Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease.
“The prequalification designation indicates that the medicine meets international standards of quality, safety and efficacy,” the WHO said in a statement.
Advertisement
Up to now, infants have been treated with formulations intended for older children – carrying a greater risk of dosage errors, side effects and toxicity.
“For centuries, malaria has stolen children from their parents, and health, wealth and hope from communities,” WHO chief Tedros Adhanom Ghebreyesus said.
“But today, the story is changing. New vaccines, diagnostic tests, next-generation mosquito nets and effective medicines, including those adapted for the youngest, are helping to turn the tide.
Advertisement
Don't Miss:
-
Russian drone strikes on Ukraine shopping centre kill 16, injure 130
-
Young Chinese women dye armpit hair as fashion statement and expression of bodily autonomy
-
Hong Kong physiotherapists face job crunch amid oversupply and budget cuts
-
Why Hong Kong’s SK Hynix fund stayed at full leverage amid market volatility
-
Malaysia’s Anwar traded reform for power. Now Umno wants it all